California Public Employees Retirement System
NGM

California Public Employees Retirement System’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

California Public Employees Retirement System’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48,500
Closed -$1.41M – 3099
2021
Q1 		$1.41M Hold
48,500
– – ﹤0.01% 2259
2020
Q4 		$1.47M Sell
48,500
-5,274
-10% -$115K ﹤0.01% 2210
2020
Q3 		$856K Buy
53,774
+786
+1% +$14.3K ﹤0.01% 2387
2020
Q2 		$1.05M Buy
52,988
+18,838
+55% +$360K ﹤0.01% 2212
2020
Q1 		$421K Buy
+34,150
New +$558K ﹤0.01% 2489

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GA
Greenspring Associates Owings Mills, Maryland $1.48B AUM 61.93% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

California Public Employees Retirement System's NGM Position: Q2 2021 in Review

California Public Employees Retirement System sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2021, closing a stake of 48,500 shares — an estimated $1.41M sold.

California Public Employees Retirement System first reported a position in NGM in Q1 2020 and held it in 5 quarters. The position peaked at $1.47M in Q4 2020. 107 funds tracked by Wall St. Rank hold NGM as of Q2 2021.

  • California Public Employees Retirement System reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 48,500 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $1.41M.
  • California Public Employees Retirement System first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
  • California Public Employees Retirement System's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.47M in Q4 2020.
  • 107 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.